首页> 外文期刊>Pediatric cardiology >Identification of Differentially Expressed Genes in Kawasaki Disease Patients as Potential Biomarkers for IVIG Sensitivity by Bioinformatics Analysis
【24h】

Identification of Differentially Expressed Genes in Kawasaki Disease Patients as Potential Biomarkers for IVIG Sensitivity by Bioinformatics Analysis

机译:通过生物信息学分析鉴定川崎病患者差异表达基因作为IVIG敏感性的潜在生物标记

获取原文
获取原文并翻译 | 示例
           

摘要

Kawasaki disease (KD) is a leading cause of acquired heart disease predominantly affecting infants and young children. Intravenous immunoglobulin (IVIG) is applied as the most favorable treatment against KD, but IVIG resistant remains exist. Although several clinical scoring systems have been developed to identify children at highest risk of IVIG resistance, there is a need to identify sufficiently sensitive biomarkers for IVIG treatment. Some differentially expressed genes (DEGs) could be the promising potential biomarkers for IVIG-related sensitivity diagnosis. We employed a systematic and integrative bioinformatics framework to identify such kind of genes. The performance of the candidate genes was evaluated by hierarchical clustering, ROC analysis and literature mining. By analyzing three datasets of KD patients, 34 DEGs of the three groups have been found to be associated with IVIG-related sensitivity. A module of 12 genes could predict resistant group patients with high accuracy, and a module of ten genes could predict responsive group patients effectively with accuracy of 96 %. And three of them are most likely to serve as drug targets or diagnostic biomarkers in the future. Compared with unsupervised hierarchical clustering analysis, our modules could distinct IVIG-resistant patients efficiently. Two groups of DEGs could predict IVIG-related sensitivity with high accuracy, which are potential biomarkers for the clinical diagnosis and prediction of IVIG treatment response in KD patients, improving the prognosis of patients.
机译:川崎病(KD)是导致后天性心脏病的主要原因,主要影响婴幼儿。静脉注射免疫球蛋白(IVIG)是抗KD的最有利治疗方法,但仍存在IVIG耐药性。尽管已经开发了几种临床评分系统来识别具有最高IVIG耐药风险的儿童,但仍需要确定足够敏感的生物标记物用于IVIG治疗。一些差异表达基因(DEGs)可能是IVIG相关敏感性诊断的有前途的潜在生物标志物。我们采用了系统的,综合的生物信息学框架来鉴定这类基因。通过分层聚类,ROC分析和文献挖掘来评估候选基因的性能。通过分析KD患者的三个数据集,发现三组中的34个DEG与IVIG相关敏感性相关。由12个基因组成的模块可以高度准确地预测抗药性患者,而由10个基因组成的模块可以有效地预测抗药性患者,其准确率达到96%。其中三个最有可能在将来用作药物靶标或诊断性生物标志物。与无监督的层次聚类分析相比,我们的模块可以有效地区分IVIG耐药患者。两组DEG可以高度准确地预测IVIG相关的敏感性,这是在KD患者中临床诊断和预测IVIG治疗反应的潜在生物标志物,可以改善患者的预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号